Merus N.V (MRUS) | Stock Overview & Key Data

$55.14

32.55%

| Merus N.V Stock Comparison:

Merus N.V vs Vertex Merus N.V vs Regeneron Merus N.V vs Moderna Merus N.V vs Corcept Therapeutics Merus N.V vs Roivant Sciences Merus N.V vs S&P 500 | Market

Chart Range Statistics Financials Dividends Returns Top Stocks Top Returns Ownership Calculator FAQ

Merus N.V Performance Comparison

Loading chart data...

Merus N.V

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $49.00 High: $57.45

on May 23, 2025

52 Week Range

Low: $33.19 High: $61.61

on April 9, 2025

on May 24, 2024

All-Time High: $61.61 on May 20, 2024

Key Statistics

Market Cap i $3.8B

EPS i -4.16

P/E Ratio (TTM) i N/A

Forward P/E i -14.14

P/B Ratio i 6.40

PEG Ratio i -14.14

Div. Yield i 0.00%

ROE i -58.66%

Beta i 0.948

Debt to Equity i 1.65

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i -285.94%

Profit Margin i 0.00%

Returns and Earnings

Return on Assets (TTM) i -30.61%

Return on Equity (TTM) i -58.66%

EBITDA i $-298.6M

Net Income (TTM) i $-277.3M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Merus N.V MRUS	3.82B Mid-cap	32.68%	31.82%	17.95%	21.48%	30.35%	-8.08%	197.57%	303.96%
Vertex VRTX	111.96B Large-cap	-0.60%	-11.46%	-9.48%	-5.57%	7.45%	-4.58%	59.28%	51.41%
Regeneron REGN	63.52B Large-cap	-1.01%	0.08%	-17.51%	-21.50%	-17.74%	-40.27%	-15.08%	-3.99%
Moderna MRNA	10.16B Large-cap	5.63%	-1.06%	-22.54%	-39.85%	-37.48%	-84.24%	-82.22%	-57.30%
Corcept Therapeutics CORT	8.34B Mid-cap	4.81%	13.60%	27.31%	33.31%	57.47%	185.94%	274.71%	419.75%
Roivant Sciences ROIV	7.76B Mid-cap	0.74%	1.21%	3.33%	-12.76%	-10.02%	-1.00%	169.06%	9.58%

Ownership & Short Interest

Insider Ownership i 1.85%

Institutional Ownership i 107.13%

Shares Short i 6M

Short Ratio i 6.63

Short % of Shares Outstanding i 8.56%

Average 10-Day Volume i 2M

Average 90-Day Volume i 1M

Merus N.V Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Merus N.V would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is MRUS's 52-week high and low?

In the last 52 weeks, Merus N.V reached a high of $61.61 (on May 24, 2024) and a low of $33.19 (on April 9, 2025).

What is the market cap and P/E ratio for MRUS?

Curious about Merus N.V's size and valuation? Its market capitalization stands at 3.82B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -14.14.

Does MRUS pay dividends? If so, what's the yield?

As for dividends, Merus N.V isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Merus N.V's main competitors or similar companies to consider before investing?

When looking at Merus N.V, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	111.96B	Healthcare	Biotechnology	-4.58%	59.28%
Regeneron REGN	63.52B	Healthcare	Biotechnology	-40.27%	-15.08%
Moderna MRNA	10.16B	Healthcare	Biotechnology	-84.24%	-82.22%
Corcept Therapeutics CORT	8.34B	Healthcare	Biotechnology	185.94%	274.71%
Roivant Sciences ROIV	7.76B	Healthcare	Biotechnology	-1.00%	169.06%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Merus N.V.? (e.g., ROE, Debt/Equity)

To get a sense of Merus N.V's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -58.66%, the Debt to Equity ratio from the most recent quarter is 1.65, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for MRUS?

Looking at Merus N.V's growth, its revenue over the trailing twelve months (TTM) was $55M. Compared to the same quarter last year (YoY), quarterly revenue grew by 235.80%, and quarterly earnings saw a YoY growth of 235.76%.

How much of MRUS stock is held by insiders and institutions?

Wondering who owns Merus N.V stock? Company insiders (like executives and directors) hold about 1.85% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 107.13%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.